Analyst Actions -- 10/20/2011

 | Oct 20, 2011 | 8:59 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

xlnx

,

csx

,

blk

,

usb

,

plcm

,

m

,

etfc

,

emn

,

abt

,

axp

,

chk

,

fcx

,

ms

Abbott Laboratories numbers raised at Goldman

Shares of ABT now seen reaching $59, according to Goldman Sachs. Estimates also increased, to match the company's new guidance. Neutral rating.

-----

Agrium upgraded at JP Morgan

AGU was upgraded to Overweight, JP Morgan said. Agriculture fundamentals are robust.

-----

American Express removed from Top Picks at Citigroup

Shares of AXP now seen reaching $58, according to Citigroup.  Estimates also lowered on Europe softness.  Maintain Buy rating.

-----

American Express estimates cut at Goldman

AXP estimates were reduced through 2013, Goldman Sachs said. Company is releasing fewer reserves. Buy rating and $56 price target.

-----

Amphenol estimates, target lowered at Citigroup

Shares of APH now seen reaching $51, according to Citigroup.  Estimates also lowered as defense spending trends remain clouded due to Washington.  Buy rating.

-----

Amphenol estimates, target cut at Credit Suisse

Shares of APH now seen reaching $49, according to Credit Suisse. Estimates also reduced, given weaker end-market demand. Outperform rating.

-----

Amphenol estimates, target lowered at UBS

Shares of APH now seen reaching $46, according to UBS.  Estimates also lowered as 4Q outlook impacted by Telecom/IT Datacom.  Neutral rating. 

-----

Apollo estimates, target increased at Citigroup

Shares of APOL now seen reaching $50, according to Citigroup.  Estimates also raised on positive outlook and regulatory concerns waning.  Neutral rating.

-----

Apollo estimates, target raised at Credit Suisse

Shares of APOL now seen reaching $52, according to Credit Suisse. Estimates also increased, given higher growth in starts. Outperform rating.

-----

BlackRock estimates increased at Citigroup

BLK estimates raised through 2012, Citigroup said.  NAVs partially offset by lower ST flows.  Maintain $180 price target and Buy rating.

-----

BlackRock estimates, target reduced at Credit Suisse

Shares of BLK now seen reaching $194, according to Credit Suisse. Estimates also cut, given lower net flows. Outperform rating.

-----

Celestica downgraded at Ticonderoga

CLS was downgraded from Buy to Neutral, Ticonderoga Securities said. Slower end-market demand could hurt growth. Company is also highly leveraged to Research in Motion.

-----

Cheesecake Factory numbers cut at Credit Suisse

Shares of CAKE now seen reaching $30, according to Credit Suisse. Estimates also reduced, as the company is struggling to leverage higher sales. Neutral rating.

-----

Chesapeake Energy rated new Buy at Sterne Agee

CHK was initiated with a Buy rating, Sterne Agee said. $40 price target. Company is cutting debt and liquids business should drive growth.

-----

Cognizant downgraded at Goldman

CTSH was downgraded to Neutral, Goldman Sachs said. Valuation call.

-----

Comerica estimates, target lowered at Credit Suisse

CMA estimates were cut through 2012, Credit Suisse said. Company is generating lower fee income and seeing higher loss provisions. Neutral rating and new $31 price target.

-----

CSX estimates, target reduced at Credit Suisse

Shares of CSX now seen reaching $28, according to Credit Suisse. Estimates also cut, given slower volume growth. Outperform rating.

-----

CSX downgraded at Wells

CSX was downgraded from Outperform to Market Perform, Wells Fargo said. Estimates also cut, as the company is seeing lower volume growth than its peers.

-----

Cubist Pharmaceuticals numbers boosted at Oppenheimer

Shares of CBST now seen reaching $46, according to Oppenheimer. Estimates also upped, given higher Cubicin sales. Outperform rating.

-----

eBay estimates lowered at UBS

EBAY estimates lowered through 2012, UBS said.  Raised guidance, mostly in line with street.  Maintain $45 price target and Buy rating.

-----

E*Trade estimates, target cut at BMO

Shares of ETFC now seen reaching $9, according to BMO Capital. Estimates also reduced, as the company is realizing lower margins. Market Perform rating.

-----

Eastman Chemical downgraded at JP Morgan

EMN was downgraded from Overweight to Neutral, JP Morgan said. $40 price target. Petrochemical returns are falling.

-----

Equifax downgraded at Goldman

EFX was downgraded to Sell, Goldman Sachs said. Company will be hurt by lower credit growth and a weaker labor market.

-----

Fiserv upgraded at Goldman

FISV was upgraded to Buy, Goldman Sachs said. Company has strong recurring revenue and can expand its margins. $67 price target.

-----

Freeport-McMoran numbers reduced at Goldman

FCX estimates were cut through 2013, Goldman Sachs said. Company is leveraged to lower copper prices. Buy rating and new $46 price target.

-----

Freeport-McMoRan estimates, target lowered at UBS

Shares of FCX now seen reaching $52, according to UBS.  Estimates also lowered on near term labor uncertainty.  Maintain Buy rating.

-----

JC Penney rated new Overweight at JP Morgan

JCP was initiated with an Overweight rating, JP Morgan said. $37 price target. Company is embarking on a potential, multi-year sales and margin turnaround.

-----

Kohl's rated new Underweight at JP Morgan

Coverage of KSS was started with an Underweight rating, JP Morgan said. $42 price target. Margins are peaking and the company has a mature store base.

-----

LAM Research Corp estimates cut at UBS

LRCX estimates lowered through 2013, UBS said.  Reflects more conservative near term outlook.  Maintain $50 price target and Buy rating.

-----

Linear Technology estimates, target lowered at UBS

Shares of LLTC now seen reaching $33, according to UBS.  Estimates also lowered as macro indicators point to bottoming fundamentals.   Buy rating.

-----

M&T Bank numbers reduced at Jefferies

MTB estimates were cut through 2012, Jefferies said. Company is seeing higher costs and realizing lower fee income. Hold rating and new $76 price target.

-----

Macy's rated new Overweight at JP Morgan

Coverage of M was started with an Overweight rating,  JP Morgan said. $36 price target. Company has several potential catalysts for sales and margin growth.

-----

Marvell technology estimates, target cut at UBS

Shares of MRVL now seen reaching $18, according to UBS.  Estimates also lowered on Thai flood impact.  Buy rating. 

-----

Mednax upgraded at Deutsche

MD was upgraded from Hold to Buy, Deutsche Bank said. $76 price target. Pullback has created an attractive buying opportunity.

-----

Monster Worldwide numbers lowered at Credit Suisse

Shares of MWW now seen reaching $18, according to Credit Suisse. Estimates also cut, given slower macro growth. Outperform rating.

-----

Morgan Stanley estimates increased Oppenheimer

MS estimates were raised through 2012, Oppenheimer said. Company has limited European exposure. Outperform rating and $27 price target.

-----

Newfield Exploration estimates, target cut at UBS

Shares of NFX now seen reaching $50, according to UBS.  Estimates also lowered as 3Q results miss expectations for a second consecutive quarter. 

-----

Nordstrom rated new Neutral at JP Morgan

JWN was initiated with a Neutral rating, JP Morgan said. $55 price target. Company is facing tougher near-term comparisons.

-----

ON Semiconductor estimates, target cut at UBS

Shares of ONNN now seen reaching $7, according to UBS.  Estimates also lowered on significant impact from Thailand floods.  Neutral rating. 

-----

Paychex upgraded at Goldman

PAYX was upgraded to Neutral, Goldman Sachs said. Company has limited downside earnings potential and the stock sports a solid dividend yield.

-----

PNC Financial Services Group estimates, target raised at Citigroup

Shares of PNC now seen reaching $54, according to Citigroup.  Estimates also increased to reflect better than expected loan growth and expense control.  Neutral rating. 

-----

Polycom estimates, target cut at BMO

Shares of PLCM now seen reaching $26, according to BMO Capital. Estimates also reduced, to match the company's new guidance. Outperform rating.

-----

Polycom downgraded at Morgan Keegan

PLCM was downgraded from Outperform to Market Perform, Morgan Keegan said. Demand is being hurt by slower macro growth. $22 price target.

-----

Polycom downgraded at Piper

PLCM was downgraded from Overweight to Neutral, Piper Jaffray said. $20 price target. Company is facing increased competition.

-----

Riverbed Technology estimates raised at UBS

RVBD estimates raised through 2012, UBS said.  Better than expected 3Q results.  Maintain $28 price target and neutral rating.

-----

Solera downgraded at Goldman

SLH was downgraded to Sell, Goldman Sachs said. Valuation call.

-----

Sonoco Products downgraded at Deutsche

SON was downgraded from Buy to Hold, Deutsche Bank said. $33 price target. Fundamentals appear to be weakening.

-----

Stryker numbers adjusted at UBS

Shares of SYK now seen reaching $59, according to UBS.  Estimates slightly raised as company is growing organic revs.  Buy rating.

-----

Tractor Supply numbers upped at Oppenheimer

TSCO estimates were boosted through 2012, Oppenheimer said. Company continues to generate solid sales growth. Perform rating and new $74 price target.

-----

United Rentals estimates raised at UBS

URI estimates increased through 2012 on a more robust demand outlook, UBS said.  Maintain $40 price target and Buy rating. 

-----

US Bancorp numbers increased at BMO

USB estimates were raised through 2012, BMO Capital said. Company is seeing higher sales growth. Outperform rating and new $31 price target.

-----

Waste Connections numbers cut at Goldman

WCN estimates were reduced through 2013, Goldman Sachs said. Company is seeing lower volumes. Neutral rating and new $37 price target.

-----

Wynn Resorts numbers cut at Morgan Stanley

Shares of WYNN now seen reaching $148, according to Morgan Stanley. Estimates also reduced, given decelerating growth in revenue from VIP customers in Macau. Equal-weight rating.

-----

Wynn Resorts estimates raised at UBS

WYNN estimates increased through 2012, UBS said.  October tracking solidly in Macau with no credit issues.  Maintain $164 price target and Buy rating.

-----

Xilinx estimates, target lowered at Jefferies

Shares of XLNX now seen reaching $32, according to Jefferies. Estimates also cut, to match the company's new guidance. Hold rating.

Columnist Conversations

The action in CAG has been very volatile this week. On Wednesday the stock was dragged down in the earl...
the longer the wait for the baba opening the more the emotions are in play...that tactic from the old playbook...
The ghost of William Wallace can get back to sleep now that Scotland is staying in the UK. Mostly stocks shou...
Katz:
TIBCO reported disappointing revenue and earnings last night and lowered their next quarter outlook. The stre...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.